Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

An interleukin 6-based genetic risk score strengthened with interleukin 10 polymorphisms associated with long-term kidney allograft outcomes

SK. Eskandari, M. Gaya da Costa, B. Faria, V. Petr, JR. Azzi, SP. Berger, MAJ. Seelen, J. Damman, F. Poppelaars

. 2022 ; 22 Suppl 4 (-) : 45-57. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032309

Of all kidney transplants, half are still lost in the first decade after transplantation. Here, using genetics, we probed whether interleukin 6 (IL-6) could be a target in kidney transplantation to improve graft survival. Additionally, we investigated if a genetic risk score (GRS) based on IL6 and IL10 variants could improve prognostication of graft loss. In a prospective cohort study, DNA of 1271 donor-recipient kidney transplant pairs was analyzed for the presence of IL6, IL6R, IL10, IL10RA, and IL10RB variants. These polymorphisms and their GRS were then associated with 15-year death-censored allograft survival. The C|C-genotype of the IL6 polymorphism in donor kidneys and the combined C|C-genotype in donor-recipient pairs were both associated with a reduced risk of graft loss (p = .043 and p = .042, respectively). Additionally, the GRS based on IL6, IL6R, IL10, IL10RA, and IL10RB variants was independently associated with the risk of graft loss (HR 1.53, 95%-CI [1.32-1.84]; p < .001). Notably, the GRS improved risk stratification and prediction of graft loss beyond the level of contemporary clinical markers. Our findings reveal the merits of a polygenic IL-6-based risk score strengthened with IL-10- polymorphisms for the prognostication and risk stratification of late graft failure in kidney transplantation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032309
003      
CZ-PrNML
005      
20230131151318.0
007      
ta
008      
230120s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ajt.17212 $2 doi
035    __
$a (PubMed)36453708
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Eskandari, Siawosh K $u Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands $u Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA $1 https://orcid.org/0000000348674170
245    13
$a An interleukin 6-based genetic risk score strengthened with interleukin 10 polymorphisms associated with long-term kidney allograft outcomes / $c SK. Eskandari, M. Gaya da Costa, B. Faria, V. Petr, JR. Azzi, SP. Berger, MAJ. Seelen, J. Damman, F. Poppelaars
520    9_
$a Of all kidney transplants, half are still lost in the first decade after transplantation. Here, using genetics, we probed whether interleukin 6 (IL-6) could be a target in kidney transplantation to improve graft survival. Additionally, we investigated if a genetic risk score (GRS) based on IL6 and IL10 variants could improve prognostication of graft loss. In a prospective cohort study, DNA of 1271 donor-recipient kidney transplant pairs was analyzed for the presence of IL6, IL6R, IL10, IL10RA, and IL10RB variants. These polymorphisms and their GRS were then associated with 15-year death-censored allograft survival. The C|C-genotype of the IL6 polymorphism in donor kidneys and the combined C|C-genotype in donor-recipient pairs were both associated with a reduced risk of graft loss (p = .043 and p = .042, respectively). Additionally, the GRS based on IL6, IL6R, IL10, IL10RA, and IL10RB variants was independently associated with the risk of graft loss (HR 1.53, 95%-CI [1.32-1.84]; p < .001). Notably, the GRS improved risk stratification and prediction of graft loss beyond the level of contemporary clinical markers. Our findings reveal the merits of a polygenic IL-6-based risk score strengthened with IL-10- polymorphisms for the prognostication and risk stratification of late graft failure in kidney transplantation.
650    _2
$a lidé $7 D006801
650    12
$a interleukin-10 $x genetika $7 D016753
650    12
$a interleukin-6 $x genetika $7 D015850
650    _2
$a prospektivní studie $7 D011446
650    _2
$a ledviny $7 D007668
650    _2
$a rizikové faktory $7 D012307
650    _2
$a alografty $7 D064591
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gaya da Costa, Mariana $u Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands $u Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands $1 https://orcid.org/0000000292015108
700    1_
$a Faria, Bernardo $u Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands $u Nephrology R&D Group, Institute for Research and Innovation in Health (i3S), São João University Hospital Center, University of Porto, Porto, Portugal
700    1_
$a Petr, Vojtech $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000260240562
700    1_
$a Azzi, Jamil R $u Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA $1 https://orcid.org/0000000269094645
700    1_
$a Berger, Stefan P $u Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
700    1_
$a Seelen, Marc A J $u Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
700    1_
$a Damman, Jeffrey $u Department of Pathology, Erasmus University Medical Center, Erasmus University, Rotterdam, The Netherlands $1 https://orcid.org/0000000159977551
700    1_
$a Poppelaars, Felix $u Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands $1 https://orcid.org/0000000251738078
773    0_
$w MED00006447 $t American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons $x 1600-6143 $g Roč. 22 Suppl 4, č. - (2022), s. 45-57
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36453708 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151314 $b ABA008
999    __
$a ok $b bmc $g 1891201 $s 1183644
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 22 Suppl 4 $c - $d 45-57 $e - $i 1600-6143 $m American journal of transplantation $n Am J Transplant $x MED00006447
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace